[Expression of chemokine receptor CCR2 in cerebral tissue of newborn rat with experimental hypoxic-ischemic brain damage].

Sichuan Da Xue Xue Bao Yi Xue Ban

Department of Pediatrics, West China Second Hospital, Sichuan University, Chengdu 610041, China.

Published: November 2007

Objective: To observe the expressions of mRNA and protein for the CCR2 in cerebral tissue with experimental hypoxic-ischemic brain damage (HIBD) to newborn rat.

Methods: The HIBD model of SD rat was set up by ligating the right carotid artery and exposing the animals to 8% oxygen for 2.5 h. The dynamic change of CCR2 mRNA level was studied by using quantitative, real-time, fluorescence PCR assay (TaqMan), and the change of CCR2 protein was detected by SDS-PAGE assay.

Results: The highest expression of CCR2 mRNA was showing at 24 h after HIBD, of which the level was significantly higher in hypoxic-ischemic (HI) cerebral hemisphere than in control (P < 0.05). The CCR2 mRNA level of 72 h after HIBD was still higher than that of control (P > 0.05) but had no difference on 7 d after HIBD when compared with control (P > 0.05). The increased expression of CCR2 protein was detected at 12 h after HIBD and peaked at 24 h after HIBD. The significant increase of CCR2 protein persisted in HI hemisphere up to 3 d after HIBD.

Conclusion: The expressions of CCR2 mRNA and protein increase significantly in cerebral tissue of newborn rat with HIBD. The dynamic change of CCR2 expression is consistent with the process of HIBD, which suggests that CCR2 expression after HIBD may play an important role in the mechanism of brain damage.

Download full-text PDF

Source

Publication Analysis

Top Keywords

ccr2 mrna
16
cerebral tissue
12
change ccr2
12
ccr2 protein
12
control 005
12
ccr2
11
hibd
10
ccr2 cerebral
8
tissue newborn
8
newborn rat
8

Similar Publications

Introduction: Primary Sjögren syndrome (pSS) is a systemic autoimmune disease that is characterized by the infiltration of immune cells into the salivary glands. The re-establishment of salivary glands (SGs) function in pSS remains a clinical challenge. Myeloid-derived growth factor (MYDGF) has anti-inflammatory, immunomodulatory, and tissue-functional restorative abilities.

View Article and Find Full Text PDF

Nutritional and metabolic state in dairy cows are important determinants of the immune response. During the periparturient period, a state of negative energy balance in the cow increases plasma concentrations of fatty acids (FA), which are associated with inflammation. Among immune cells, CD4 T are able to function under high-FA conditions, but the underlying mechanisms regulating these events remain unclear.

View Article and Find Full Text PDF

Chemokine CCL2 and its receptor CCR2 in different age groups of patients with COVID-19.

BMC Immunol

October 2024

Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Background: Despite the development of various antiviral drugs, most of them are not effective in the treatment of coronavirus disease 2019 (COVID-19) as a hyperinflammatory disorder. Chemokine (C-C motif) ligand 2 (CCL2) is one of the critical CC chemokines involved in the pathogenesis and severity of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. This study aimed to investigate the expression of CCL2 and CC chemokine receptor 2 (CCR2) in COVID-19 patients.

View Article and Find Full Text PDF

Background And Aims: Osteopontin (OPN) promotes the ductular reaction and is a major driver of chronic liver disease (CLD) progression. Although CLD is characterised by the accumulation of inflammatory cells including macrophages around the peri-portal regions, the influence of OPN on recruitment is unclear. We investigated the role of OPN in cholangiocyte chemokine production and macrophage recruitment by combining in vivo, in vitro, and in silico approaches.

View Article and Find Full Text PDF

The pathogenesis of myelocytomatosis oncogene (MYC) and B-cell lymphoma 2 (BCL2) double-expressor diffuse large B-cell lymphoma (DE-DLBCL) remains unclear. To investigate how MYC and BCL2 contribute to tumor aggressiveness, we analyzed tumors from 14 patients each with DE-DLBCL and non-DE-DLBCL using whole transcriptome sequencing. Validation was performed using publicly available data sets, tumor tissues from 126 patients, DLBCL cell lines, and a syngeneic mouse lymphoma model.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!